Company: HCWB
Filing Date: 2025-08-15
Form Type: 8-K
Source: 0000950170-25-109139
Chunk: 0

Company: HCW Biologics Inc.
Filing Date: 2025-08-15
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01 Entry into a Material Definitive Agreement.

As previously reported on February 21, 2025, HCW Biologics Inc. (the “ Company,”, “we,” “us,” or “our”) and Square Gate Capital Master Fund, LLC- Series 4 (the “ Investor”) entered into an Equity Purchase Agreement (the “ ELOC EPA”) pursuant to which the Company has the right, but not the obligation, to sell to the Investor, and the Investor will have the obligation to purchase from the Company, up to $20,000,000 (the “ Maximum Commitment Amount”) worth of the Company’s shares of common stock, at the Company’s sole discretion, over the 36-month period following its effective date (the “ Put Shares”), subject to certain conditions precedent and other limitations. On August 14, 2025, the Company and the Investor entered into a First Amendment to the ELOC EPA (the “ First Amendment”) to provide a mechanism for submission by the Company and acceptance by the Investor of Put Notices under the ELOC EPA pursuant to which the Investor and the Company may agree to and execute multiple purchases and sales of Put Shares on the same trading day. Under the First Amendment, among other things, the purchase price of the intraday Put Shares will be the lowest traded price during a specified shortened valuation time period. The foregoing summary of certain terms of the ELOC EPA and the First Amendment does not purport to be complete.